KRAS and lung adenocarcinoma: KRAS mutation, a common driver of lung adenocarcinoma, is associated with KEAP1 loss-of-function mutations in approximately 20% of KRAS mutant NSCLC cases, forming a KRAS-KEAP1 co-mutation (KK) type.